A newly developed chest drainage unit with an integrated CO2 detector
| ISRCTN | ISRCTN13725610 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13725610 |
| Secondary identifying numbers | Acadre 17/33766 |
- Submission date
- 13/06/2019
- Registration date
- 01/07/2019
- Last edited
- 01/07/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Plain English summary of protocol
Background and study aims
Air leakage following thoracic surgery is common and leads to increased morbidity, costs and length of hospitalization. An air leak not caused by an alveolo-pleural fistulae (true air leak) is termed false air leak. Unrecognized false air leakage results in unnecessarily prolonged chest tube duration, costs and risks of complications. The correct interpretation of whether the air leakage is true or false is consequently paramount to correct decision making and timing of safe chest drain removal.
Unfortunately, both traditional water seal and electronic drainage systems cannot distinguish false air leakage from true air leakage. The aim of the present study was to test a new chest drainage unit, where a CO2-sensitive colour indicator is integrated into the chest drainage unit to distinguish true air leakage form false air leakage.
Who can participate?
All of the patients that are eligible for surgery are informed before surgery by a doctor in written form and oral. All patients signing an informed consent form are included in the pilot study.
What does the study involve?
During a period of three weeks, 14 consecutive adult male and woman are operated in Dep of Cardiothoracic surgery, OUH, Denmark with open surgery and VATS surgery with minor resections of the lung (subsegmental resections) and major resections of the lung (lobectomies and bilobectomies). All patients are operated in general anaesthesia with double lumen intubation.
After the pilot study using only the chest drainage unit with CO2 indicator for all patients, the trial will continue with measurement of intrathoracic pressure with a pressure indicator inserted in the thoracic cavity. Pressure measurement will be performed for patients with the new chest drainage, a standard chest drainage unit and a digital chest drainage unit.
What are the possible benefits and risks of participating?
There are no direct benefits for the persons taking part in the trial. The risks are the same as risks involved in having a chest tube in general (wound infection, pain).
Where is the study run from?
Odense University Hospital
When is the study starting and how long is it expected to run for?
April 2019 to May 2020
Who is funding the study?
The study is funded by the Odense University Hospital and the Southern Denmark University Research & Innovation Organisation. The 14 chest drainage units are delivered without payment from the manufacturer Sinapi Biomedicals.
Who is the main contact?
Consultant Jens Eckardt
jens.eckardt@rsyd.dk
Contact information
Scientific
JB Winsløw 4
Odense
5000
Denmark
| Phone | +4524621770 |
|---|---|
| jens.eckardt@rsyd.dk |
Study information
| Study design | pilot feasibility, observational case-control study |
|---|---|
| Primary study design | Observational |
| Secondary study design | Case-control study |
| Study setting(s) | Hospital |
| Study type | Other |
| Participant information sheet | Not available in web format, please use the contact details below to request a participant information sheet. |
| Scientific title | A newly developed chest drainage unit with an integrated CO2 detector: an observational case-control study |
| Study acronym | N/A |
| Study objectives | Postoperative observed air leakage does not always originate from parenchymal defects but may arise from defects in the chest drainage unit, connections or reverse airflow in water seals. The aim of the present study was to test a new invention in the clinic, where a CO2-sensitive colour indicator is integrated in the chest drainage unit. |
| Ethics approval(s) | The ethics board for the region of southern Denmark decided that there was no need for approval from an ethics committee. |
| Health condition(s) or problem(s) studied | Lung surgery, either open surgery or vats (video-assisted thoracoscopic surgery) |
| Intervention | All persons included in the trial according to the inclusion criteria are operated according to the recommendations in the department. Surgery is performed in general anesthesia and after the resection of the lung tissue, a chest tube (silicone tube ) is inserted. In the trial involving intrathoracic pressure measurement, an additional tube (plastic tube) is inserted (thickness 2-4 millimeter). When there is no air leakage from the lung tissue both tubes are removed followed by a chest x-ray after 2-4 hours. The operated persons are discharged from the hospital according to the recommendations in the department. The trial does not involve any follow-up. All information is collected from patient records. The trial run from the day of surgery until the person has been discharged from the hospital. |
| Intervention type | Device |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure | 1. The complication rate is measured by collecting data from patient records. 2. Chest tube reinsertion rate is measured by collecting data from patient records. 3. The length of chest tube duration is measured by collecting data from patient records. 4. The length of stay is measured using by collecting data from patient records. |
| Secondary outcome measures | The number of patients with false air leakage versus true air leakage is measured by collecting data from patient records. |
| Overall study start date | 01/07/2018 |
| Completion date | 01/06/2020 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | 50 |
| Key inclusion criteria | 1. Aged 18 to 90 years. 2. Open or vats procedures with non-small lung cancer or undiagnosed lesions. 3. Lobectomies, bilobectomies or diagnostic resections of lung tissue. |
| Key exclusion criteria | Patients who cannot give informed consent. |
| Date of first enrolment | 01/04/2019 |
| Date of final enrolment | 01/05/2019 |
Locations
Countries of recruitment
- Denmark
Study participating centre
Odense
5000
Denmark
Sponsor information
Hospital/treatment centre
JB Winsløw vej 4
Odense C
5000
Denmark
| Phone | +4566 11 33 33 |
|---|---|
| ouh.kontakt@rsyd.dk | |
| Website | www.ouh.dk |
"ROR" |
https://ror.org/00ey0ed83 |
Funders
Funder type
University/education
No information available
No information available
Results and Publications
| Intention to publish date | 01/09/2019 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Other |
| Publication and dissemination plan | Planned publication in an internationally recognized journal focused on Cardiothoracic Surgery. |
| IPD sharing plan | The datasets generated and/or analysed during the current study during this study will be included in the subsequent results publication. |
Editorial Notes
14/06/2019: Trial's existence confirmed by the Scientific Ethics Committees
for the Region of Southern Denmark.
